The treatment of patients with low tumour burden and/or slow growing disease.
In the evaluation of the wide range of novel therapeutics which have been developed, investigators do not have to be tied to the current paradigm of demonstrating additive efficacy to first line combination therapy. The addition of new agents to FOLFOX regimens has proved a high hurdle at which many...
Главный автор: | Maughan, T |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2011
|
Схожие документы
-
The response of fast-, medium- and slow-growing chickens to a low protein diet
по: Darina Chodová, и др.
Опубликовано: (2021-03-01) -
Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?
по: Magaly Zappa, и др.
Опубликовано: (2017-02-01) -
STING signalling compensates for low tumour mutation burden to drive anti-tumour immunityResearch in context
по: Jiayi Tan, и др.
Опубликовано: (2024-03-01) -
Slow growing of Stieltjes integrals of monotone functions
по: M. V. Zabolotskyj, и др.
Опубликовано: (2013-01-01) -
Cassava residues in the diet of slow-growing broilers
по: Silvia Silva VIEIRA, и др.
Опубликовано: (2022-09-01)